Lates News

Teva Pharmaceuticals' stock rose by 0.7%. After the US FDA issued a warning about nitrosamine contamination risks, Teva Pharmaceuticals voluntarily recalled over 580,000 bottles of pantoprazole hydrochloride. This recall is classified as a Class II risk.